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Abstract 
 
Phosphorylation by the cyclin-dependent kinase 1 (Cdk1) adjacent to nuclear localization 
segments (NLSs) is an important mechanism of regulation of nucleocytoplasmic transport. 
However, no systematic survey has yet been performed in human cells to analyze this regulatory 
process, and the corresponding cell-cycle dynamics have not yet been investigated. Here, we 
focused on the human proteome and found that numerous proteins, previously not identified in 
this context, are associated with Cdk1-dependent phosphorylation sites adjacent to their NLSs. 
Interestingly, these proteins are involved in key regulatory events of DNA repair, epigenetics, or 
RNA editing and splicing. This finding indicates that cell-cycle dependent events of genome 
editing and gene expression profiling may be controlled by nucleocytoplasmic trafficking. For in-
depth investigations, we selected a number of these proteins and analyzed how point mutations, 
expected to modify the phosphorylation ability of the NLS segments, perturb nucleocytoplasmic 
localization. In each case, we found that mutations mimicking hyper-phosphorylation abolish 
nuclear import processes. To understand the mechanism underlying these phenomena, we 
performed a video microscopy-based kinetic analysis to obtain information on cell-cycle 
dynamics on a model protein, dUTPase. We show that the NLS-adjacent phosphorylation by 
Cdk1 of human dUTPase, an enzyme essential for genomic integrity, results in dynamic cell 
cycle-dependent distribution of the protein. Non-phosphorylatable mutants have drastically 
altered protein re-import characteristics into the nucleus during the G1 phase. Our results 
suggest a dynamic Cdk1-driven mechanism of regulation of the nuclear proteome composition 
during the cell cycle.  
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 Introduction 
 
Eukaryotic cells distribute proteins into various cellular compartments and these intracellular 
trafficking processes are under multiple levels of control. The transport of large macromolecules 
into and out of the nucleus depends on karyopherins, a group of proteins specifically recognizing 
short peptide segments in cargo proteins 1. Peptide segments involved in these processes are 
termed nuclear localization signals and nuclear export signals (NLSs and NESs, respectively) 2. 
The recognition of NLS and NES sequences by karyopherins can be effectively modulated by 
introducing negatively charged phosphate groups adjacent to the localization signals via protein 
phosphorylation. Such modifications have been shown to have a drastic effect on changing the 
cellular distribution of several proteins3-5. The most extensive studies in this respect have been 
performed in yeast, while the human proteome has not yet been systematically investigated in 
this context 6.  
 
The best-characterized nuclear import pathway employs the transport factors importin-α (Impα; 
also known as karyopherin-α), and importin-β (Impβ). Impα recognizes the cargo in the 
cytoplasm through binding to the classical nuclear localization signals (cNLSs), and the cargo 
enters the nucleus through nuclear pore complexes as a trimeric Impα:Impβ:cargo complex. The 
directionality of transport through the nuclear pore complexes is determined by the small 
GTPase Ran, which has an asymmetric distribution of its nucleotide-bound states between the 
cytoplasm and the nucleus; it binds to Impβ inside the nucleus in its GTP-bound state, 
dissociating the import complex and releasing the cargo. Most cNLSs contain either one 
(monopartite) or two (separated by a linker sequence of usually 10-12 residues; bipartite) 
clusters of positively charged amino acids. Combining structural studies and interaction data for 
various cNLSs and their mutants has enabled the molecular understanding of the cNLS:Impα 
recognition and the definition of cNLS consensus sequences. Impα contains two cNLS-binding 
regions, the major and minor sites. Bipartite cNLSs span both binding sites, while monopartite 
cNLSs usually bind preferentially to the major site. Individual amino acids in the cNLS bind to 
specific pockets in the cNLS-binding sites; in the bipartite cNLS consensus KRX10-12KRRK (X 
corresponds to any amino acid) 7, the N-terminal basic cluster corresponding to positions P1’–
P2’ binds to the minor site, while the C-terminal cluster corresponding to positions P2–P5 binds 
to the major site. 
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Phosphorylation of proteins is mediated by protein kinases. The specificity of phosphorylation by 
a particular kinase depends on the composition of residues flanking the phosphorylation site (so-
called peptide specificity) 8, although it is further influenced by the context that the kinase finds 
itself in, including various forms of substrate recruitment 9. For example, the core consensus 
sequence for cyclin-dependent kinase 1 (Cdk1)-dependent phosphorylation sites has been 
described as [S/T*]-P-X-[K/R], where S/T* is the phosphorylated serine or threonine 10-12. More 
extensive analyses of known substrates and other available experimental data have uncovered 
further more subtle determinants of specificity for Cdk1 and other protein kinases 8, 13, 14 
 
Both NLSs and phosphorylation motifs can be described as linear motifs. Linear motifs are short 
sequences found most frequently in the disordered regions of proteins, and usually function in 
cellular signaling and regulation, by binding to protein interaction domains or by being the target 
of post-translational modifications 15. Although they pose difficulty for computational analysis 
because of their small size, significant progress has been made in the recent years in the 
computational identification of a number of different types of linear motifs and the integration of 
diverse types of experimental data into these computational approaches 15. In particular, we 
have developed some of the most reliable approaches for the identification of NLSs 16 and 
protein phosphorylation sites 13, 17. While computational predictions are often hampered by less 
than desired accuracies, combined prediction of two associated motifs can in fact lead to 
increased accuracy 18. 
 
The composition of the nuclear proteome defines the availability of the different proteins within 
the cell nucleus for dedicated functions. The role of cell-cycle dependent nucleocytoplasmic 
trafficking in regulatory processes of gene expression regulation, DNA damage and repair, and 
other genome editing pathways have been partially investigated in yeast 6 but have not yet been 
assessed systematically in mammalian cells. A fundamental difference between the two systems 
is the closed mitosis of yeast. During closed mitosis the nuclear membrane remains intact and 
the microtubule-based spindle extends within the nucleus 19. In case of open mitosis, cells 
temporally lack their nuclear envelope in M phase. Thus, after mitosis the nuclear proteome has 
to be reconstituted from proteins that had passively diffused into the cytoplasm (expect for the 
ones chromatin associated) and become excluded from the nucleus as the newly forming 
nuclear envelope is initially tightly attached to chromatin 20. The modulation of the nuclear re-
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import of cargoes could give an additional layer of regulation of nuclear proteome composition 
throughout the cell cycle. 
 
In the present study, we first carried out a computational analysis of the human proteome to 
identify putative regulatory Cdk1-dependent phosphorylation sites in the vicinity of NLSs in 
nuclear proteins. We then validated the computational predictions experimentally for a number of 
proteins, comparing the nucleocytoplasmic localization of hyper-phosphorylation mimicking 
(hyper-P; with a glutamic acid substitution) and non-phosphorylatable hypo-phosphorylation 
(hypo-P; with a glutamine substitution) mutants to the phosphorylatable wild-type (WT) protein in 
a new cellular assay. Finally, we selected one particular protein as an in-depth case study to 
analyze the dynamics of phosphorylation-regulated nuclear transport during the cell-cycle. We 
selected human dUTPase, a protein involved in genomic integrity 21, for this case study; where 
we have previously characterized the molecular and structural basis of NLS-adjacent 
phosphorylation on nuclear import 22. Namely, the introduction of negative charge into the P-1 
position rearranges the accommodation pattern of the dUTPase NLS in the importin-α NLS 
binding site. This results in the loss of critical hydrogen bonds between the importin-α surface 
and the NLS peptide, impairing nuclear import 22. Here, we show that Cdk1-dependent 
phosphorylation of dUTPase results in a scheduled dynamic pattern of nuclear availability in the 
newly-formed daughter cells. Jointly, our results uncover a ubiquitous mechanism for the 
regulation of nuclear trafficking of human proteins by Cdk1 during the cell cycle and provide a 
molecular explanation for the negative regulation of nuclear import by NLS-adjacent Cdk1-
dependent phosphorylation. 
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Results/Discussion 
 
The effect of NLS-adjacent phosphorylation on nucleocytoplasmic protein distribution during the 
cell cycle 
 
Earlier publications identified several yeast 6 and human proteins 3, 4, 23, where NLS-adjacent 
phosphorylation was shown to inhibit nuclear import. In these cases, phosphorylation took place 
at either the P0 or the P-1 positions of the NLS, immediately N-terminal to the large basic cluster 
of the NLS 24. Yeast Cdc28 or its human orthologue Cdk1 were proposed to be responsible for 
most of these phosphorylation events, thus giving these proteins a cell cycle-specific localization 
pattern 6. Cdc28 and Cdk1 phosphorylate a number of proteins that control critical cell cycle 
events, including DNA replication and segregation, transcriptional programs and cell 
morphogenesis 25. The available results clearly argue for the importance of Cdk1-kinase-
regulated nuclear transport for several yeast proteins involved in the regulation of cell cycle 
progression, DNA replication, DNA damage recognition and repair. As we presently show, 
similar regulation may occur for human proteins of similar function (Table 1). 
 
We set out to perform a human proteome-wide bioinformatics screen with the aim of identifying 
human proteins possessing a Cdk1-dependent phosphorylation site at either P0 or P-1 positions 
of their NLS. We combined two state-of-the-art bioinformatics tools for prediction of NLSs 
(NucImport 16) and phosphorylation sites (Predikin 13) that we ourselves developed previously. 
NucImport uses a probabilistic (Bayesian network) approach to recognize a variety of NLSs by 
integrating amino acid sequence and interaction data and predicts the sequence position of the 
NLS, out-performing other available methods 16. Predikin uses the concept of specificity-
determining residues to predict peptide specificity of protein kinases and identify substrates for 
protein kinases 14, 17, 26; the tool outperformed other competing tools in the protein kinase section 
of the Peptide Recognition Domain specificity prediction category of the 2009 DREAM4 
challenge (an independent test using unpublished data) 13. We first used Predikin 13 to determine 
how often a Ser or Thr residue was predicted to be phosphorylated, regardless of the import 
status or presence of NLS. This background frequency of phosphorylation was determined to be 
0.136 (c.f. Experimental Procedures). We then used NucImport 16 to predict the location of 
classical NLSs. For each NLS location, we determined the frequency of (predicted) 
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phosphorylation of the P0 position to be 0.393 (p = 2.348e-30) and of the P-1 position to be 
0.234 (p = 9.530e-05). Hence, both positions are significantly enriched for phosphorylation. 
 
Overall, with a conservative setting of both predictors (see Experimental Procedures for details), 
we found 92 proteins with a phosphorylation site in the P0 position and 44 proteins with a 
phosphorylation site in the P-1 position, considering all protein isoforms (if considering only 
parent proteins, this corresponds to 50 and 22, respectively; Table S1). Among these proteins, 
there are numerous examples for which, to our knowledge, no previous experimental data have 
been reported as being relevant to phosphorylation-dependent nuclear translocation. Using 
Gene Ontology (GO) term annotations, we found proteins involved in DNA damage recognition 
and repair, gene expression, epigenetics, RNA-editing and several transcription factors (Table 1 
and S2). For any of these functions, strict and regulated scheduling of nuclear availability has 
clear and imminent significance, arguing for the need for further direct experimental study. We 
therefore selected several identified proteins for experimental validation. 
 
Cellular screen to evaluate NLS function for selected proteins 
 
To efficiently test the effect of phosphorylation on nuclear import for a number of proteins, we 
designed a sensitive model system. We chose DsRed-monomer labeled β-galactosidase, a well-
described bacterial protein, as an inert fluorescent cargo, upon which different NLSs can be 
attached. The construct is strictly cytoplasmic, unless fused to a functional NLS, such as the 
well-established SV40 large T-antigen (TAg) NLS (Figure 1A). In order to evaluate phenotypic 
characteristics of any further NLSs, we set a measure scale for five distinct cellular distribution 
patterns (Figure 1B). We tested this NLS reporter system using the WT and mutant NLSs of the 
Swi6 protein (Figure 2A), which has been previously described to be phosphorylated at the P-1 
position of its NLS by Cdc28, resulting in the inhibition of its nuclear transport 6, 27-29. The 
mutations were introduced in such a way that the negative charge mimicking the phosphorylated 
residue was introduced either at the P-2, P-1 or P0 positions 24, while the structurally important 
proline residue was not perturbed (Figure 2B).  
 
The results argue that the exact position of the phosphorylated residue is a crucial determining 
factor in the localization of NLS-containing cargo. Our results are in good agreement with 
previous work proposing that phosphorylation at P0 or P-1 positions impedes nuclear import, 
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while on the other hand, phosphorylation at upstream positions, for example in the P-2 position, 
have the opposite effect by enhancing nuclear import 30.  
 
Using the validated screening system, we tested a selection of proteins involved in a variety of 
cellular functions (Table 1 and references therein). Our selections included six proteins with 
predicted Cdk1 phosphorylation sites at the P0 position, and seven proteins with predicted Cdk1 
phosphorylation sites at the P-1 position (Table S3). The resulting localization data in Figure 3 
show that in each case, substitution of the appropriate Ser or Thr, predicted to be 
phosphorylated by Cdk1, by Glu (hyper-P mimicking) consistently leads to significantly weaker 
nuclear accumulation or even to complete nuclear exclusion, compared to the WT protein. The 
efficiency of nuclear targeting differed among the different NLSs. Our experimental data further 
argue for the inhibitory effect of the phosphorylation at the P-1 and P0 positions on nuclear 
import, and confirms the validity of the in silico analysis. Among the hits of the in silico screening 
dUTPase was not present due to the strict settings NucImport. However its NLS was tested in 
our reporter system, which showed nuclear exclusion upon Glu substitution in the P-1 position in 
agreement with our previous data on full length protein (Figure S1A) 22. Our analysis thus 
identified numerous human proteins potentially sharing a similar Cdk1-driven regulatory pattern 
(Table 1 and S1). These proteins are involved in crucial cellular functions such as DNA damage 
recognition and repair, transcriptional regulation, cell cycle control, epigenetics and RNA editing. 
 
For several proteins where NLS-adjacent Cdk1-driven phosphorylation has been reported 
previously, its actual effects could not be properly deciphered when using only hypo-P mimicking 
mutants in static or kinetic experiments. Therefore, we checked the effect of hyper-P mimicking 
mutations at the previously established Cdk1 sites of UNG2 (S14 phosphorylation 31, 32), UBA1 
(S4 phosphorylation 33) and p53 (S315 and S312 phosphorylation in human and in mouse, 
respectively 34) (Figure 4). The NLS segments were cloned into our pGal-DsRed NLS reporter 
construct and the full length ORFs were fused with DsRed-monomer for localization studies. 
These phosphorylation sites are predicted to be located in the P-2 position adjacent to their 
NLSs. As expected, a negative charge introduced at this position did not abolish the nuclear 
localization of either of these constructs (both with the NLS reporter and the full length proteins). 
However, if we used mutagenesis to move this negative charge to the P-1 position, the impeding 
effect on nuclear import is clearly observable in case of UBA1 and UNG2 (Figure 4) with the 
NLS reporter constructs. In case of the UNG2 it is clearly visible that the nuclear localization is 
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enhanced in the S14E mutant (in P-2 position), and the nuclear targeting capability of the WT 
NLS is evident when compared to the NLS impaired mutant, K18N (Figure S1B and C) 35. 
Phosphorylation of the P-2 positions might enhance nuclear accumulation of these proteins after 
mitosis. Possible reason why the full length UNG2 does not show the same localization pattern 
as the NLS reporter construct is that it has a complex NLS which not exclusively relies on the 
S14PARKRHA sequence. Perturbation of this segment does not lead to complete nuclear 
exclusion, other sequences also have a role in proper localization of UNG2 35. p53, which 
harbors a bipartite NLS sequence, might have the flexibility to compensate these negative 
effects by the additional binding to the minor NLS-binding site.  
 
Video microscopy-based kinetic analyses 
 
To have a better understanding of the effect of the described phosphorylation on the dynamic 
distribution of proteins throughout the cell cycle, we used dUTPase as a model. This enzyme 
catalyzes the hydrolysis of dUTP into dUMP and inorganic pyrophosphate 36-38 preventing dUMP 
incorporation into DNA 39, 40. dUTPase is an important contributor to genomic integrity from 
bacteria to human 21, 41-46 and possesses a nuclear isoform in different eukaryotes 41, 47, 48. We 
have previously shown that the cell cycle-dependent phosphorylation of dUTPase by Cdk1 at the 
S11 position (which is located in the P-1 position of its NLS 47, 49) abolishes its nuclear import 
and is linked to M phase 23.  
 
In order to follow the dynamic alterations of dUTPase localization pattern during the cell cycle, 
we followed individual cells after transfection with the appropriate fluorescent constructs by video 
microscopy. The dUTPase pool exhibits marked cell cycle-dependent dynamic behavior (Figure 
5A). When the new nuclear envelope appears, dUTPase is excluded from the nucleus. Following 
cytokinesis, it takes a considerable time before the nuclear space is again re-populated with WT 
dUTPase (Video S1 left panel). Interestingly, for the S11Q mutant, the nuclear repopulation 
dynamics is markedly different (Video S1 right panel). The S11E mutant, by contrast, remains 
cytoplasmic during the entire cell cycle (Video S2). 
 
Using this approach, we could measure apparent rate constants for nuclear re-accumulation of 
the WT and the S11Q mutant dUTPases (Figure 5B). The same approach cannot be applied to 
the S11E mutant, as it never enters the nucleus in our experiments. We found that the major 
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difference between the WT protein and the S11Q mutant is that the WT protein re-enters the 
nucleus with a considerable lag. Following the lag phase, the apparent rate constants of nuclear 
accumulation are identical for the WT protein (kobs = 0.0044 min-1 ± 7%) and for the S11Q mutant 
(kobs = 0.0043 min-1 ± 8%). Importantly, the mean total fluorescence of the cells (Fn+c) did not 
change during our observations (Figure 5B inset), indicating the steady-state of the investigated 
fluorescent protein pool. The apparent single exponential kinetics we observe likely represents 
the result of multiple undistinguishable transport events. The fact that the wild type protein and 
the non-phosphorylatable mutant S11Q show different kinetic behaviour is clearly due to the 
change in their phosphorylatable properties.  
 
In order to directly address the pattern of nucleocytoplasmic trafficking of a given protein pool, 
we repeated the video-microscopy experiments by transfecting the fluorescent proteins 
themselves, instead of plasmids that lead to continuous expression. Cells transfected with 
recombinantly expressed WT and S11Q DsR-DUT proteins show the same dynamic events of 
dUTPase pool distribution as those in the plasmid transfection experiments (Figure S2 and 
Videos S3-S4). 
 
To investigate whether the exogenous DsR-DUT constructs (originating either from transfected 
plasmids or the recombinant protein itself) used in the video-microscopy experiments can be 
phosphorylated similarly to the endogenous protein, we performed western blot experiments 
(Figure 5C and Figure S3B). We used a dUTPase-specific antibody generated against the full-
length protein (anti-hDUT 44), in combination with the dUTPase S11-phosphoserine specific 
antibody (anti-S11P-hDUT 23). Figure 5C shows that 293T cells transfected with the appropriate 
fusion protein-encoding plasmids produce a WT DsR-DUT protein pool that can be 
phosphorylated. The recognition of dUTPase by the anti-S11P-hDUT antibody is observed only 
if Ser11 can be phosphorylated, providing evidence for the specificity of this antibody. The 
endogenous dUTPase pool is also visible at a lower molecular mass position. Neither forms of 
recombinant proteins produced in E. coli are recognized by the anti-S11P-hDUT antibody, 
indicating that they are not phosphorylated at Ser11 (Figure S3B). Within the cells transfected 
with recombinantly produced DsR-DUT protein itself, however, the cognate phosphorylation 
event targeting Ser11 can take place. The anti-hDUT antibody recognizes all dUTPase construct 
forms, as well as the endogenous dUTPase pool, independently of the point mutation or 
phosphorylation state (Figure S3B). 
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The P-mimicking mutation leads to the exclusion from the nucleus, resulting in an interesting 
observation that the nuclei of the daughter cells become populated with dUTPase protein only 
after a significant delay. These results indicate that the potential of the WT protein to be 
phosphorylated within the nucleus may have physiological implications manifested in its retarded 
re-import in the daughter cells. The non-phosphorylatable S11Q construct does not exhibit this 
behavior. We suggest that this mechanism may also operate for the proteins listed in Table S1, 
because they contain similar phosphorylatable NLSs. Assuming similar nuclear re-import 
characteristics as that of dUTPase, Cdk1 kinase-induced phosphorylation at these NLS positions 
would significantly alter the nuclear proteome re-establishment in the daughter cells after the M 
phase (Figure 6). 
 
Biological significance of cell-cycle dependent re-shaping of the nuclear proteome 
 
Our studies suggested that Cdk1 kinase-induced phosphorylation of many human proteins 
potentially alter their localization patterns during the cell cycle. Specifically, the most detailed 
kinetic analysis performed in our case study using dUTPase indicated that the re-import into the 
nucleus is delayed significantly if the relevant site close to the NLS segment is phosphorylated. 
Although the mechanism by which this cell-cycle-dependent localization pattern is governed 
seems to be general (cf Figure 6), the exact physiological consequences of these effects depend 
on the actual protein and its role in cellular pathways. Below, we discuss these protein-specific 
characteristics. 
 
In the case of dUTPase, Cdk1-induced phosphorylation of the protein within the nucleus at the 
G2/M phase will have a prominent effect on the dUTPase pool localization in daughter cells. 
Namely, dUTPase nuclear import is hampered until the phosphate moiety is removed, thus 
nuclear re-population in the daughter cells takes place only after a considerable time delay. 
dUTPase nuclear accumulation reaches its maximal extent around the S phase and the protein 
remains strictly nuclear until the onset of mitosis (Figure 5A). Recently, it has been shown that 
nuclear localization of the de novo thymidylate biosynthesis pathway is required for the 
maintenance of genomic integrity 50. This is achieved by sumoylation-mediated nuclear transport 
of the enzymes of the pathway, composed of thymidylate synthase (TYMS), dihydrofolate 
reductase (DHFR), and serine hydroxymethyltransferase (SHMT1 and SHMT2α) 51, 52. For all 
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these enzymes, this partial nuclear translocation takes place at the onset of S phase, and they 
remain in the nucleus until the G2/M phases, while they are cytoplasmic during G1 phase, 
enabling de novo thymidylate synthesis during DNA replication and repair 53. dUTPase catalyzes 
the hydrolysis of dUTP into pyrophosphate and dUMP; ensuring the substrate for TYMS, and 
also low cellular dUTP/dTTP ratios, thus inhibiting uracil accumulation in the DNA 21. Here we 
show that dUTPase nuclear accumulation also reaches its maximal extent during the S phase, 
similarly to the de novo thymidylate biosynthesis enzymes. Because it was suggested that de 
novo thymidylate biosynthesis does not occur in the cytoplasm at rates sufficient to prevent 
uracil misincorporation into DNA 50, it is reasonable to propose that dUTPase might also be 
necessary to accompany this enzyme complex into the nucleus for proper genomic DNA 
maintenance. Partially due to S phase activation of ribonucleotide reductase subunits, regulated 
by transcriptional and post-transcriptional processes, the dNTP pool in mammalian cells 
increases 20-fold at this cell cycle stage compared to G1 54. Thus scheduled nuclear availability 
of de novo thymidylate biosynthesis enzymes, along with dUTPase and ribonucleotide 
reductase, may ensure strictly regulated dNTP pool composition for DNA polymerases.          
      
Table 1 provides a list for other human proteins where we found potential Cdk1 sites and 
suggest that phosphorylation regulates their nuclear import and thus their availability in the 
nucleus. These proteins are involved in crucial cellular functions such as DNA damage 
recognition and repair, transcriptional regulation, cell cycle control, epigenetics and RNA editing. 
Clearly, for proteins involved in such functions, the fine-tuned regulation of nuclear availability is 
of high significance. For example, cullin-4B plays a role in cell cycle regulation together with 
cyclin-L2, which is also involved in pre-mRNA splicing, alongside with apoptosis induction and 
cell-cycle arrest in cancer cells. The ataxia telangiectasia and Rad3-related protein, BRCA1-A 
complex subunit RAP80 and histone acetyltransferase p300 are key components of DNA 
damage repair. We also found that many of these proteins may act in an interconnected manner; 
for example, during DNA damage, the protein kinase ATR phosphorylates the bromodomain 
adjacent to Zn-finger domain protein 2a, the BRCA1-A complex subunit RAP80, the Ras-
responsive element binding protein 1, and the Ser/Arg repetitive matrix protein 2 55. For proteins 
involved in DNA repair (ATR, cullin 4B, BRCA1-A subunit RAP80, transcription factor AP-4), the 
tight connection between cell-cycle checkpoints and DNA damage recognition and response 
pathways may be the underlying reason for their scheduled absence or presence within the 
nucleus 56. Such regulation of protein subcellular distribution may assist in maintaining the 
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correct logistics of scheduling and executing different tasks during the cell cycle along with the 
regulation of mRNA nucleocytoplasmic trafficking 57. In such a way, the use of crucial 
metabolites involved in energy and signal transduction can also be correctly distributed among 
cell division, replication and repair tasks. Interestingly, examination of SNP databases revealed 
two instances where a given SNP may overwrite the Cdk1 driven regulation, however, no data 
for either frequency or physiological relevance of these SNPs has been reported (Table S1). 
 
Conclusions 
 
Dynamic exchange of macromolecules between the cytoplasm and the nucleus is regulated by 
several mechanisms. Here we suggest that nuclear import is significantly delayed for those 
cellular proteins where a Cdk1 kinase-dependent phosphorylation event occurs during the M 
phase at a relevant site in the vicinity of the NLS (Figure 6).  
 
Two bioinformatics tools, namely NucImport and Predikin, were used to identify the scope of the 
hypothesized mechanism and to isolate candidate targets. We established the statistical basis 
for identifying relevant hits and their functional (gene ontology) associations, in ways not 
supported by the tools individually. Albeit not implemented as a tool in its own right, our 
integrated approach, may help to develop further studies that aim to understand how (other) 
post-translational modifications can dynamically modulate functions of sequence motifs 
(including localization signals). Our analysis showed that (i) positions P-1 and P0 relative to 
predicted human NLSs are both significantly enriched for predicted Cdk1 phosphorylation; and  
(ii) 44 and 92 protein isoforms (with phosphorylation of NLS P-1 and P0 sites, respectively) are 
associated with a range of functions that require strict and regulated scheduling of nuclear 
availability.  
 
Our cellular reporter assay confirmed the computational predictions of proteins regulated by 
NLS-adjacent phosphorylation and showed that Cdk1 phosphorylation at P-1 and P0 positions of 
human NLSs impedes nuclear import. Although the observed effects may be modulated in the 
full-length proteins, our results clearly provide proof-of-concept. Namely, we propose that the cell 
cycle-dependent changes in the nuclear proteome may have an important role in selecting the 
correct set of proteins to be present in the nucleus during the different stages of the cell cycle. 
Cdk1 phosphorylation events at the M phase will result in proteins that cannot be re-imported 
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into the nucleus after cytokinesis, because phosphorylation of the P-1 and P0 positions impedes 
their binding to importin-α. Therefore, several proteins will only appear in the nucleus of the 
daughter cells after a significant delay following dephosphorylation or de novo protein synthesis. 
Dephosphorylation in the cytoplasm may require some time and might be under yet another 
level of regulation, giving cells further plasticity in fine-tuning their nuclear proteome. The 
regulatory pattern we described may prevent accumulation of proteins within the nucleus that 
could perturb cellular functions, for example by initiating expression of genes with an incorrect 
schedule. This regulation might also be further fine-tuned by cytoplasmic anchoring processes, 
facilitated by phosphorylation events 58. However, the exact purpose of this regulation might 
differ for each protein, and should be checked individually in detail. 
 
Cell cycle-dependent changes in the nuclear proteome are of utmost importance in the prompt 
regulation of cellular events, and protein kinases such as Cdk1 cooperate to control the cell 
cycle dynamics. After cell mitosis, daughter cells form their own nuclear envelope and begin with 
a limited set of proteins that remain strictly adherent to the chromosomes during cytokinesis 20. 
Organism, like yeast, with closed mitosis rely on active protein transport in every phase of their 
cell-cycle while cells with open mitosis thus have the unique opportunity of re-setting the protein 
composition within the nucleus of daughter cells after every division. We conclude that Cdk1-
driven phosphorylation at P-1 or P0 positions of the NLSs makes a significant contribution to this 
re-shaping process of the nuclear proteome after the M phase. 
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Materials and methods 
 
Computational analyses of NLSs and phosphorylation motifs 
The computational tools Predikin 13 and NucImport 16 were used to analyze the human 
proteome. Protein sequences were obtained from UniProt 59 as the complete human proteome 
including all known isoforms, as defined by UniProt complete proteome sets (representing a total 
of 71,809 sequences).  
To predict the location of nuclear localization signals, we used NucImport 16. NucImport predicts 
the probability of nuclear import, type of classical NLS (as categorized by 60) and its exact 
location in any query protein sequence. Apart from sequence properties, the prediction is based 
on known (human) protein interactions that are retrieved from BioGRID 61. We refer to the 
predicted proteome set as those proteins that were assigned a type-1 classical NLS with a 
probability of 0.95 or greater.  
Cdk1 phosphorylation sites were predicted for all potential sites, i.e., all Ser and Thr residues, 
using Predikin 13. As we used the Cdk1 matrix to score all potential phosphorylation sites in the 
human proteome, we obtained the complete distribution of scores associated with Cdk1. 
Converting these to a cumulative density allowed us to (empirically) determine p-values 
associated with each Predikin score (the p-value is the probability of achieving a score at least 
as high as the one observed). 
We looked for enrichment of phosphorylation at the P0 and P-1 sites relative to the (predicted) 
NLS in each protein in the nuclear proteome by counting, for each NLS site, all potential 
phosphorylation sites (i.e., all Ser and Thr sites) that do not occur at the NLS site of interest and 
recorded whether they are above or below a threshold (Predikin p-value = 0.1).  From these 
counts, the ratio of phosphorylation sites/potential sites can be calculated for the background, P0 
and P-1 positions.  We assessed whether observations at P0 and P-1 differed from the 
background by performing a χ² analysis. 
Gene Ontology (GO) term enrichment analysis was performed for identified proteins using 
Fisher's exact test. Specifically, we used all proteins predicted to have a type-1 classical NLS 
and a predicted phosphorylation site at either P0 or P-1 as a foreground, and all “reviewed” 
human proteins in UniProtKB as background. We used the Gene Ontology official release of 
human annotations (as of February 2012). For each biological process GO term, we counted the 
number of proteins in the foreground set and the background set with this term. The one-tailed 
Fisher’s exact test establishes the p-value of the term: the probability of finding this protein count 
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or more extreme (greater proportion in the foreground). The p-value was corrected for multiple 
testing (shown as E-value). A term is thus assigned a small E-value only if proteins annotated 
with that term occur in the foreground set with a higher prevalence than can be statistically 
explained by chance (i.e. proteins picked randomly from the background set). 
 
Cell culture and constructs 
293T cells were kindly provided by Prof. Yvonne Jones (Cancer Research UK, Oxford). Cells 
were cultured in DMEM/F12 HAM (Sigma) supplemented with Penicillin–Streptomycin solution 
(50 µg/ml; Gibco) and 10% FBS (Gibco). dUTPase nuclear isoform (DUT) fused to DsRed-
Monomer (DsR-DUT) was described in 23. DsR-DUT was further cloned into the NdeI/XhoI sites 
of the vector pET-20b (Novagen) for recombinant protein expression (with oligonucleotides 
dutpETF and dutpETR). Human tumor protein p53 cDNA was purchased from OriGene 
(NM_000546.2). p53 was fused to DsRed-Monomer, by cloning it into the XhoI/BamHI sites of a 
modified pEGFP-C1 vector (Clontech) (with primers p53_F and p53_R), where EGFP was 
replaced by DsRed-Monomer (within the NheI/XhoI sites of the vector). Ubiquitin-activating 
enzyme E1 (UBA1) cDNA was purchased from OriGene (NM_003334.2) and the fusion 
construct was made cloning it into the KpnI/BamH1 sites of the pDsRed-Monomer-N1 vector 
(Clontech) (with primers UBA1_F and UBA1_R). Human Uracil-DNA glycosylase 2 (UNG2) 
cDNA was a generous gift of Professor Salvatore Caradonna and was cloned into the XhoI/KpnI 
sites of the pDsRed-Monomer-N1 vector (with primers UNG2_F and UNG2_R). Site-directed 
mutagenesis was performed by the QuickChange method (Stratagene). The NLS reporter 
construct was created by fusing β-galactosidase with DsRed-Monomer (termed pGal-DsRed). β-
galactosidase was amplified lacking its start codon from the vector pCAUG (with oligos galN1F 
and galN1R), and was cloned into the KpnI/EcoRI sites of the vector pDsRed-M-N1, thus 
generating the vector termed pGal-DsRed. Single-stranded oligonucleotide pairs, listed in Table 
S4, encoding different NLS peptides were cloned into the NheI/EcoRI sites of the pGal-DsRed 
vector after annealing. In addition, the vector pHM830 (Addgene plasmid 20702) (AflII/XbaI 
sites) was also used to generate constructs for the NLSs that showed a strong tendency for 
aggregation when used in context of the previously described pGal-DsRed construct 62. Primers 
used for cloning and mutagenesis were synthesized by Eurofins MWG GmbH and are 
summarized in TableS4. All constructs were verified by sequencing at Eurofins MWG GmbH. 
 
Fluorescence imaging and analysis of DsRed-tagged constructs 
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For DNA transfections, LipofectamineTM LTX (Invitrogen) was used according to the 
manufacturer’s instruction.  Briefly, subconfluent cultures of 293T cells grown in 35 mm Petri 
dishes were incubated with 1-2 µg DNA along with 10 µl LTX reagent in serum-free medium, for 
16 hours. Protein transfection was performed according to the manufacturer’s protocol using 
Pro-DeliverINTM reagent (OZ Biosciences). In brief, 8-10 µg protein and 15 µl transfection 
reagent was used to deliver DsRed-tagged proteins into the cells for 14-18 hours. Image 
analysis to quantify relative subcellular localization was performed from single-cell 
measurements using ImageJ 1.46j (NIH, Bethesda), where the mean nuclear (Fn) and 
cytoplasmic (Fc) fluorescence ratio (Fn/c) was measured within each cell. Statistical analysis of 
the relative subcellular localization changes was carried out by the InStat 3.05 software 
(GraphPad Software, San Diego California, USA) using the non-parametric Mann-Whitney test. 
Differences were considered statistically significant at p<0.05. Images were either acquired with 
a Leica DM IL LED Fluo microscope equipped with a Leica DFC345 FX monochrome camera. 
 
Live-cell microscopy and evaluation 
Time-lapse recordings were performed on a Zeiss 200M inverted microscope equipped with an 
AxioCam Mnr camera and controlled by the AxioVision 4.8 software. Cells were cultured in Ibidi 
dishes and kept at 37°C in a humidified 5% CO2 atmosphere within custom-made microscope 
stage incubator (CellMovie). Images were acquired every 5 minutes for at least 24 hours using a 
10X magnification objective. After transfection, the cells were washed three times with a serum-
containing medium. Time-lapse imaging started one hour after changing the medium. Addition of 
serum resulted in the flattening of the cells and mitogenic serum factors boosted cell 
proliferation. 
Plasmid transfection experiments. The kinetic treatment of the imaging data addresses the gross 
kinetics of nuclear dUTPase accumulation and does not aim to carry out a detailed analysis of 
the underlying processes. The quantification of fluorescence in single cells from each frame was 
performed using ImageJ 1.46j (NIH, Bethesda), where the mean nuclear (Fn) and cytoplasmic 
(Fc) fluorescence were measured. Data points represent mean values extracted from 16 cells in 
triplicates. The time axis was defined relative to the visual observation of cytokinesis i.e. t = 0 at 
cytokinesis termination. The observed fluorescence intensity increase in the nucleus could be 
analysed, as the total fluorescence of the cytoplasmic and nuclear compartments (Fn+c) was 
constant during the time period of the analysis. Single exponential kinetics fit well to the rising 
phase of the nuclear accumulation curves in both the WT and the S11Q mutant cell lines. The 
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considerable lag in nuclear fluorescence accumulation in the WT cells was not included in the 
kinetic analysis due to the lack of information on building a comprehensive kinetic model for the 
whole trafficking process. 
Protein transfection experiments. These image sequences were not subjected to densitometric 
analyses due to lower intensity of the intracellular fluorescent signal as well as to the higher 
background (Videos S3 and S4). The time elapsed between the onset of cytokinesis and the 
appearance of fluorescent signal within the nucleus (Figure S2) was determined by careful visual 
observation. Considerable nuclear accumulation of fluorescent proteins was declared when the 
fluorescent intensity within the nucleus exceeded that within the cytoplasm. Parallel phase 
contrast images were used to determine the onset of cell cleavage. 
Both DNA and protein transfection-based experiments yielded the same conclusions regarding 
the dynamic distribution pattern of the WT and S11Q mutant DsR-DUT. This is potentially due to 
the fact that the DsRed-labeled proteins can only be detected after a considerable time delay 
following protein translation, partially because of the time required for maturation of DsRed 
fluorophore and because of the time required for detectable fluorophor accumulation. 
Furthermore, newly maturing DsRed molecules (which also went through phosphorylation in M 
phase) might be in steady state with a degradation process. Because of these effects, the DsR-
DUT pool translated during the recording time of video-microscopy used for analysis (~12 hours) 
does not contribute to the fluorescent signal. The observable fluorescent signal of the mature 
folded protein molecules thus necessarily originates from the protein pool translated during the 
cell cycle(s) completed prior to start of the video recording. 
 
Immunoblot analysis 
Phosphorylation of the constructs after cellular delivery was investigated using immunblot 
analysis. Cells were collected, washed twice with PBS, and resuspended in the lysis buffer (50 
mM TRIS·HCl pH=7.4; 140 mM NaCl; 0,4% NP-40; 2 mM dithiothreitol (DTT); 1 mM EDTA, 1 
mM phenylmethylsulfonyl fluoride; 5 mM benzamidin, CompleteTM EDTA free protease inhibitor 
cocktail tablet (Roche), PhosSTOPTM phophatase inhibitor cocktail tablet (Roche)). Cell lysis was 
achieved by sonication. Insoluble fraction was removed by centrifugation (20,000 x g x 15 min at 
4°C). Protein concentration was measured with Bio-Rad Protein Assay to ensure equivalent total 
protein load per lane. Products were resolved under denaturing and reducing conditions on a 
15% polyacrylamide gel and transferred to PDVF membrane (Immobilon-P, Millipore). 
Membranes were blocked with 5% nonfat dried milk, incubated with primary antibodies for 2 
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hours at room temperature. After washing the membranes secondary antibodies coupled with 
horseradish peroxidase were applied (Amersham Pharmacia Biotech and Sigma). 
Immunoreactive bands were visualized by enhanced chemiluminescence reagent (Amersham) 
and recorded on X-ray film (Kodak). Antibodies to detect the following proteins were used in 
western blotting: anti-hDUT (1:5000) 44, anti-S11P-hDUT (1:200, GenScript). 
 
Recombinant protein production 
DsRed-tagged dUTPase constructs were expressed in Rosetta BL21 (DE3) pLysS bacteria 
strain and purified using Ni-NTA affinity resin (Qiagen). Transformed cells growing in Luria broth 
medium were induced at A600nm=0.6 with 0.6 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) 
for 16 hours at 20ºC. Cells were harvested and lysed in lysis buffer (50 mM TRIS·HCl, pH=8.0, 
300 mM NaCl, 0.5 mM EDTA, 0.1% Triton X-100, 10 mM 2-mercaptoethanol, 1 mM 
phenylmethylsulfonyl fluoride; 5 mM benzamidin, CompleteTM EDTA free protease inhibitor 
cocktial tablet (Roche)) with sonication and cell debris was pelleted by centrifugation at 20.000 x 
g for 30 minutes. Supernatant was applied onto a Ni-NTA column and washed with lysis buffer 
containing 50 mM imidazole. dUTPase was finally eluted with elution buffer (50 mM HEPES, 
pH=7.5, 30 mM KCl, 500 mM imidazole, 10 mM 2-merchaptoethanol). dUTPase constructs were 
dialyzed against buffer containing: 20 mM HEPES, pH=7.4, 140 mM NaCl, 1 mM MgCl2 and 2 
mM dithiothreitol (DTT). The proteins were >95 % pure as assessed by SDS-PAGE.  
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Figure legends: 
 
Figure 1. Representation of relative NLS activity. 
(A) The β-galactosidase-DsRed (pGal-DsRed) reporter construct is strictly cytoplasmic, unless 
fused to a functional NLS, such as the SV40 large T-antigen (TAg) NLS. Scale bar represents 20 
µm. 
(B) The reporter construct was fused with various NLSs to generate constructs with different 
extents of nuclear localization. Localization was categorized into five types: N (completely 
nuclear), Nc (mainly nuclear), NC (homogenous distribution between the nucleus and 
cytoplasm), nC (mainly cytoplasmic), C (completely cytoplasmic). Scale bar represents 20 µm. 
 
Figure 2. Position-specific effect of phosphorylation on NLSs. 
(A) Performance of the reporter system (pGal-DsRed) after fusing Swi6 WT and mutant NLSs to 
the construct. Fn/c ratios (± standard error of the mean) were determined as described in the 
Experimental Procedures section. Localization pattern was categorized according to Figure 1B. 
Scale bar represents 20 µm. 
(B) Glutamic acid at P-2 or P0 was introduced by insertion of Ala in P0 or deletion of Leu in P1. 
Sequences were aligned as predicted to bind to the NLS-binding pockets of importin-α 24. 
 
Figure 3. Evaluation of the proteins identified by computational analysis: cellular screens 
for NLS activity. 
Localization patterns of proteins selected based on proteome-wide analysis. DNA corresponding 
to NLSs was cloned into the pGal-DsRed reporter system, and localization was tested in 293T 
cells. P-mimicking mutations at the appropriate Ser/Thr position in most cases significantly 
reduced nuclear accumulation. Scale bar represents 20 µm. 
 
Figure 4. Effect of phosphorylation on localization of Cdk1 substrate proteins. 
UNG2 (residue S14), UBA1 (residue S4) and p53 (residue S315) phosphorylation at the P-2 
positions of their NLSs were mimicked by Glu substitution in the pGal-DsRed reporter system or 
were mutated in full length proteins fused to DsRed-monomer. Localization was tested in 293T 
cells.. Scale bar represents 20 µm. 
 
Figure 5. Phosphorylation-dependent cellular localization patterns of dUTPase. 
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(A) Live-cell microscopy of daughter cells. Transfected 293T cells were observed during at least 
one full cell cycle. Still images were taken from Video S1. The once-nuclear pool gets slowly re-
imported into the nucleus.  
(B) Kinetic analysis of protein re-import dynamics of the daughter cells indicate similar import 
kinetics but different lag phases for the WT protein and the S11Q mutant (kobs = 0.0044 min-1 ± 
7% and 0.0043 min-1 ± 8%, respectively).  
(C) Western blot shows cognate phosphorylation of exogenous dUTPases. 
 
Figure 6. Reconstitution of the nuclear proteome after cell division. 
Schematic diagram of the model of nuclear proteome re-setting through regulation of nuclear 
import by Cdk1 phosphorylation during the cell cycle in human cells. 
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Table 1. Proteins covering different functions within the cell selected for further analysis 
from the proteome-wide screen 
Proteins for which the phosphorylation of the particular NLS adjacent residues were experimentally 
confirmed, according to derived from the Phosida database (http://www.phosida.com/) 63, 64 are 
indicated in italics. 
 
Function Protein name Abbreviation 
NLS sequence Ref. 
DNA damage 
recognition 
and repair 
Ataxia telangiectasia and Rad3-
related protein ATR SPKRRRLS 
65 
BRCA1-A complex subunit 
RAP80 UIMC1 SVKRKRRL 
66, 67 
Cullin-4B CUL4B TSAKKRKL 68 
Transcription factor AP-4 TFAP4 SPKRRRAE 69 
Histone acetyltransferase p300 EP300 SAKRPKLS 70 
Ras-responsive element-
binding protein 1 RREB1 SPLKRRRL 
71 
Regulation of 
gene 
expression 
Ras-responsive element-
binding protein 1 RREB1 SPLKRRRL 
72 
Histone acetyltransferase p300 EP300 SAKRPKLS 73 
Transcription factor AP-4 TFAP4 SPKRRRAE 69, 74, 75 
Epigenetics 
Histone acetyltransferase p300 EP300 SAKRPKLS 70 
Bromodomain adjacent to zinc 
finger domain protein 2A BAZ2A SPSKRRRL 
76, 77 
Cullin-4B CUL4B TSAKKRKL 78 
RNA 
editing/splicing 
Ser-Arg repetitive matrix protein 
2 SRRM2 TPAKRKRR 
79 
Cyclin-L2 CCNL2 SPKRRKSD 80 
Cell cycle 
regulation 
Cullin-4B CUL4B TSAKKRKL 81-83 
Cyclin-L2 CCNL2 SPKRRKSD 80, 84 
Development 
T-cell leukemia homeobox 
protein 3 TLX3 TPPKRKKP 
85 
Transcription factor AP-4 TFAP4 SPKRRRAE 69 
Nuclear 
skeleton Lamin A LMNA SVTKKRKL 
86, 87 
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Supplemental Data 
 
Figure S1. dUTPase and UNG2 NLSs in the pGal-DsRed reporter assay 
(A) dUTPase NLS was cloned into the pGal-DsRed reporter assay. Localization was tested in 
293T cells. P-mimicking mutations at the appropriate Ser/Thr position in most cases significantly 
reduced nuclear accumulation. Scale bar represents 20 µm. 
(B) UNG2 NLS was cloned into the pGal-DsRed reporter assay. Localization was tested in 293T 
cells. Comparision of the WT NLS peptide with the K18N mutated NLS argues for the NLS 
function of the segment. Scale bar represents 20 µm. 
(C) Positioning of the NLS residues within the major NLS-binding site of importin-α. Localization 
pattern is indicated for each NLS. 
 
 
Figure S2. Live cell microscopy after protein transfection. 
Still images taken from Movies S4 and S5 showing 293T cells expressing WT and S11Q mutant 
dUTPase during cell division and G1 phase, after protein transfection. The differences observed 
between in the dynamics of shuttling between the two forms correlate well with those described 
with the plasmid-transfected cells. 
The inserted table shows the time (minutes) elapsed between the onset of cytokinesis and the 
appearance of considerable fluorescent signal within the nucleus. Data were collected from 
fluorescent time-lapse image sequences taken in 5 min intervals. Parallel phase contrast images 
were used to determine the onset of daughter cell separation (cleavage). 
 
Figure S3. S11 phosphorylation status of recombinant dUTPase constructs 
(A) After protein transfection both recombinant DsR-DUT and DsR-DUT S11Q localize to the 
nucleus, as in the case of plasmid transfection. Scale bar represents 20 µm. 
(B) Neither forms of recombinant proteins produced in E. coli are recognized by the anti-S11P-
hDUT antibody, indicating that they are not phosphorylated at Ser11. DsR-DUT can be 
phosphorylated similarly to the endogenous protein. 
3 
 
Video S1 
Localization dynamics of WT DsR-DUT as compared to the non-phosphorylatable mutant S11Q 
DsR-DUT during the cell cycle in 293T-HEK cells 16 hours after plasmid transfection. 
 
Video S2 
Localization dynamics of the hyper-phosphorylation mimick S11E DsR-DUT construct during the 
cell cycle in 293T-HEK cells 16 hours after plasmid transfection. 
 
Video S3 
Localization dynamics of the WT DsR-DUT recombinantly produced construct during the cell 
cycle in 293T-HEK cells 14-18 hours after protein transfection. 
 
Video S4 
Localization dynamics of the S11Q DsR-DUT recombinantly produced construct during the cell 
cycle in 293T-HEK cells 14-18 hours after protein transfection. 
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Table S1. Proteins with a predicted type-1 classical NLS and a predicted Cdk1 
phosphorylation site at the P0 position or P-1 position. 
The table excludes isoforms of the parent protein. Proteins for which the phosphorylation of the 
particular NLS adjacent residues were experimentally confirmed, according to data derived from the 
Phosida database (http://www.phosida.com/) are indicated in italics.  
 
Supplemented as an individual .xls file 
 
5 
 
Table S2. Gene Ontology term enrichment report for proteins with predicted class-1 NLS 
and Cdk1 phosphorylation site at the P0 or P-1 position. 
The table shows the output of a GO enrichment analysis of proteins with predicted NLSs and 
phosphorylation sites (72 proteins (isoforms excluded) from UniProtKB with 1310 unique 
biological process terms) relative to the complete human proteome (20246 proteins retrieved 
from UniProtKB with 10726 unique biological process terms) using Fisher’s exact test. The E-
value is a Bonferroni corrected p-value. We only list GO terms with E-value < 0.01. For each 
significant term, we also specify the number of assigned “hit” proteins vs. the “total” number 
found in the complete background set. 
 
Supplemented as an individual .xls file 
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Table S3. Predicted binding to the major NLS-binding site of importin-α and nuclear 
localization of proteins selected by our proteome-wide analysis and their mutants 
 
 NLS binding to major binding site of importin-α Localization
 P-2 P-1 P0 P1 P2 P3 P4 P5 P6  
ATR wta A I S P K R R R L N 
ATR mutb A I E P K R R R L Nc 
CCNL2 wta A A S P K R R K S nC 
CCNL2 mutb A A E P K R R K S C 
TFAP4 wta A S S P K R R R A NC 
TFAP4 mutb A S E P K R R R A NC 
CUL4B wta A T S A K K R K L N 
CUL4B mutb A T E A K K R K L N 
EP300 wta A P S A K R P K L N 
EP300 mutb A P E A K R P K L Nc 
UIMC1 wta A V S V K R K R R NC 
UIMC1 mutb A V E V K R K R R C 
RREB1 wta A S P L K R R R L N 
RREB1 mutb A E P L K R R R L NC 
LMNA wta L S V T K K R K L Nc 
LMNA mutb L E V T K K R K L NC 
BAZ2A wta L S P S K R R R L N 
BAZ2A mutb L E P S K R R R L NC 
TFAP4 wta A S S P K R R R A NC 
TFAP4 mutb A E S P K R R R A C 
CUL4B wta A T S A K K R K L N 
CUL4B mutb A E S A K K R K L Nc 
TLX3 wta A T P P K R K K P Nc 
TLX3 mutb A E P P K R K K P nC 
SRRM2 wta A T P A K R K R R Nc 
SRRM2 mutb A E P A K R K R R NC 
 
a wild-type 
b hyper-P mimic mutant 
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Table S4. Oligonucleotides and peptides used in the study 
 
Supplemented as an individual .xls file 
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Q9H9L7 22 SPKRRRCA Akirin-1
Q53H80 21 SPKRRRCA Akirin-2
Q15699 129 SSKKRRHR ALX homeobox protein 1
Q13535 428 SPKRRRLS Serine/threonine-protein kinase ATR
Q9NYF8 114 SPKRRSVS Bcl-2-associated transcription factor 1
Q9H0E9 77 TPKRKRGE Bromodomain-containing protein 8
Q96S94 400 SPKRRKSD Cyclin-L2
O14646 1328 SSKRRKAR Chromodomain-helicase-DNA-binding protein 1
P49759 27 SHKRRKRS Dual specificity protein kinase CLK1
Q8N684 417 SRKRHRSR Cleavage and polyadenylation specificity factor
Q13620 53 SAKKRKLN Cullin-4B
Q09472 12 SAKRPKLS Histone acetyltransferase p300
P17096 53 TPKRPRGR High mobility group protein HMG-I/HMG-Y
P52926 44 SPKRPRGR High mobility group protein HMGI-C
Q9NV88 564 SGKKRKRV Integrator complex subunit 9
O43679 254 TTKRRKRK LIM domain-binding protein 2
P43364 16 SIKRKKKR Melanoma-associated antigen 11
Q02078 496 SVKRMRMD Myocyte-specific enhancer factor 2A
Q06413 461 SVKRMRLS Myocyte-specific enhancer factor 2C
Q8N5Y2 334 TPKRRKAE Male-specific lethal 3 homolog
Q659A1 757 SKKRKKIR NMDA receptor-regulated protein 2
O00712 268 SSKRPKTI Nuclear factor 1 B-type
O00567 556 SKKKRKFS Nucleolar protein 56
Q14207 1366 TTKKRKIE Protein NPAT
Q7Z417 220 TPKKRKAR Nuclear fragile X mental retardation-interacting protein 2
Q96QT6 240 SSKRRRKE PHD finger protein 12
Q8TF01 551 SPKRKKRH Arginine/serine-rich protein PNISR
Q8NAV1 245 SPKRRSPS Pre-mRNA-splicing factor 38A
Q13523 349 SPKRRSLS Serine/threonine-protein kinase PRP4 homolog
Q8NDT2 19 SAKRPRER Putative RNA-binding protein 15B
Q96LT9 115 SEKKKRSD RNA-binding protein 40
P0 position
Uniprot NLS sequence Protein namePhosphorylation position
Q13127 541 TKKKKKVE RE1-silencing transcription factor
O15446 459 STKKRKKQ DNA-directed RNA polymerase I subunit RPA34
Q14690 41 STKRKKSQ Protein RRP5 homolog
Q9Y6X0 620 TKKRKRRR SET-binding protein
O95104 442 SPKRRRSR  Arginine/serine-rich splicing factor 15
O15042 991 TPKRSRRS U2 snRNP-associated SURP motif- containing protein
Q08170 391 SKKKKKED Serine/arginine-rich splicing factor 4
Q16629 217 SPKRSRSP Serine/arginine-rich splicing factor 7
Q8IWZ8 378 TVKRKRKS SURP and G-patch domain-containing protein 1
P54274 347 STKKKKES Telomeric repeat-binding factor 1
Q12789 1214 SQKRKRLK General transcription factor 3C polypeptide 1
Q01664 124 SPKRRRAE Transcription factor AP-4
Q15583 162 SGKRRRRG Homeobox protein TGIF1
Q13769 5 SSKKRKPK THO complex subunit 5 homolog
O15405 243 TPKKKKKK TOX high mobility group box family member 3
Q9NPG3 187 SPKKRKLK Ubinuclein-1
Q5T4S7 3366 STKKSKKE E3 ubiquitin-protein ligase UBR4
Q96RL1 29 SVKRKRRL BRCA1-A complex subunit RAP80
Q96JG9 3786 STKRKKGQ Zinc finger protein 469
Q9UIF9 1783 SPSKRRRL Bromodomain adjacent to zinc finger domain protein 2A
Q9NSI6 905 SPPKRRRK Bromodomain and WD repeat-containing protein
Q8N684 416 SSRKRHRS Cleavage and polyadenylation specificity factor
Q13620 52 TSAKKRKL Cullin-4B
O75618 175 SQRKRRKS Death effector domain-containing protein
Q9NPF5 459 SSVKKAKK DNA methyltransferase 1-associated protein 1
Q03001 1382 SPVKRRRM Dystonin
Q92522 31 SPSKKRKN Histone H1x
P02545 414 SVTKKRKL Prelamin-A/C
Q15788 30 STEKRRRE Nuclear receptor coactivator 1
Q14207 1365 STTKKRKI Protein NPAT
O94913 475 STRKRSRS Pre-mRNA cleavage complex 2 protein Pcf11
P-1 positions
Uniprot NLS sequence Protein namePhosphorylation position
Q8TF01 550 SSPKRKKR Arginine/serine-rich protein PNISR
Q8NDT2 18 SSAKRPRE Putative RNA-binding protein 15B
Q13127 540 STKKKKKV RE1-silencing transcription factor
Q92766 161 SPLKRRRL Ras-responsive element-binding protein 1
Q9UQ35 2599 TPAKRKRR Serine/arginine repetitive matrix protein 2
Q08170 390 SSKKKKKE Serine/arginine-rich splicing factor 4
Q01664 123 SSPKRRRA Transcription factor AP-4
O43763 153 TPPKRKKP T-cell leukemia homeobox protein 2
O43711 162 TPPKRKKP T-cell leukemia homeobox protein 3
Q5T4S7 3365 SSTKKSKK E3 ubiquitin-protein ligase UBR4
AKIRIN1 C1orf108
AKIRIN2 C6orf166
ALX1 CART1
ATR FRP1
BCLAF1 BTF KIAA0164
BRD8 SMAP SMAP2
CCNL2 SB138
CHD1
CLK1 CLK 
CPSF7
CUL4B KIAA0695
EP300 P300
HMGA1 HMGIY
HMGA2 HMGIC
INTS9 RC74
LDB2 CLIM1
MAGEA11 MAGE11
MEF2A MEF2
MEF2C
MSL3 MSL3L1
NARG2 BRCC1 UNQ3101/PRO10100
NFIB rs146765479
NOP56 NOL5A
NPAT CAND3 E14
NUFIP2 KIAA1321 PIG1
PHF12 KIAA1523
PNISR C6orf111 SFRS18 SRRP130 
HSPC261 HSPC306
PRPF38A
PRPF4B KIAA0536 PRP4 PRP4H 
PRP4K
RBM15B OTT3
RNPC3 KIAA1839 RBM40 RNP
Gene name SNPs at P0 position
REST NRSF XBR
CD3EAP ASE1 CAST PAF49
PDCD11 KIAA0185
SETBP1 KIAA0437
SCAF4 KIAA1172 SFRS15
U2SURP KIAA0332 SR140
SRSF4 SFRS4 SRP75
SRSF7 SFRS7
SUGP1 SF4
TERF1 PIN2 TRBF1 TRF TRF1
GTF3C1
TFAP4 BHLHC41
TGIF1 TGIF
THOC5 C22orf19 KIAA0983
TOX3 CAGF9 TNRC9
UBN1
UBR4 KIAA0462 KIAA1307 RBAF600 
ZUBR1
UIMC1 RAP80 RXRIP110
ZNF469 KIAA1858
BAZ2A KIAA0314 TIP5
BRWD1 C21orf107 WDR9
CPSF7
CUL4B KIAA0695
DEDD DEDPRO1 DEFT KE05
DMAP1 KIAA1425
DST BP230 BP240 BPAG1 DMH DT 
KIAA0728
H1FX
LMNA LMN1
NCOA1 BHLHE74 SRC1
NPAT CAND3 E14
PCF11 KIAA0824
Gene names SNPs at P-1 position
PNISR C6orf111 SFRS18 SRRP130 
HSPC261 HSPC306
RBM15B OTT3
REST NRSF XBR
RREB1 FINB
SRRM2 KIAA0324 SRL300 SRM300 
HSPC075
SRSF4 SFRS4 SRP75
TFAP4 BHLHC41
TLX2 HOX11L1 NCX
TLX3 HOX11L2 rs139496015
UBR4 KIAA0462 KIAA1307 RBAF600 
ZUBR1
1.50E-17 1.40E-21 GO:0090304 39/1924 Nucleic acid metabolic process
8.40E-14 7.83E-18 GO:0006139 39/2453 Nucleobase-containing compound metabolic process
1.50E-13 1.40E-17 GO:0016070 30/1298 RNA metabolic process
7.50E-12 6.99E-16 GO:0045934 24/847 Negative regulation of nucleobase-containing compound metabolic process
9.30E-12 8.67E-16 GO:0051172 24/855 Negative regulation of nitrogen compound metabolic process
1.50E-11 1.40E-15 GO:0010467 30/1538 Gene expression
1.90E-11 1.77E-15 GO:0034641 39/2871 Cellular nitrogen compound metabolic process
3.20E-11 2.98E-15 GO:0051252 39/2916 Regulation of RNA metabolic process
6.20E-11 5.78E-15 GO:0051253 22/741 Negative regulation of RNA metabolic process
7.20E-11 6.71E-15 GO:0006807 39/2986 Nitrogen compound metabolic process
2.30E-10 2.14E-14 GO:0044260 44/4028 Cellular macromolecule metabolic process
3.90E-10 3.64E-14 GO:0006396 20/630 RNA processing
4.80E-10 4.48E-14 GO:0019219 40/3341 Regulation of nucleobase-containing compound metabolic process
9.10E-10 8.48E-14 GO:0010468 39/3221 Regulation of gene expression
1.10E-09 1.03E-13 GO:0051171 40/3422 Regulation of nitrogen compound metabolic process
2.30E-09 2.14E-13 GO:0010605 24/1098 Negative regulation of macromolecule metabolic process
3.40E-09 3.17E-13 GO:2000113 21/802 Negative regulation of cellular macromolecule biosynthetic process
3.70E-09 3.45E-13 GO:0031324 24/1123 Negative regulation of cellular metabolic process
3.70E-09 3.45E-13 GO:0006397 16/386 mRNA processing
6.50E-09 6.06E-13 GO:0010558 21/830 Negative regulation of macromolecule biosynthetic process
2.10E-08 1.96E-12 GO:0009892 24/1217 Negative regulation of metabolic process
2.70E-08 2.52E-12 GO:0008380 14/300 RNA splicing
3.60E-08 3.36E-12 GO:0031327 21/908 Negative regulation of cellular biosynthetic process
4.20E-08 3.92E-12 GO:0060255 41/4013 Regulation of macromolecule metabolic process
4.40E-08 4.10E-12 GO:0045892 19/715 Negative regulation of transcription, DNA-dependent
4.90E-08 4.57E-12 GO:0009890 21/923 Negative regulation of biosynthetic process
7.30E-08 6.81E-12 GO:0006351 16/470 Transcription, DNA-dependent
9.80E-08 9.14E-12 GO:0043170 44/4749 Macromolecule metabolic process
2.10E-07 1.96E-11 GO:0080090 41/4214 Regulation of primary metabolic process
2.50E-07 2.33E-11 GO:0010629 19/790 Negative regulation of gene expression
E -value p -value GO term
Hits/Total (with 
GO term)
GO term description
4.30E-07 4.01E-11 GO:0031323 41/4302 Regulation of cellular metabolic process
7.10E-07 6.62E-11 GO:0006355 33/2829 Regulation of transcription, DNA-dependent
8.40E-07 7.83E-11 GO:2001141 33/2846 Regulation of RNA biosynthetic process
9.10E-07 8.48E-11 GO:0052472 6/21 Modulation by host of symbiont transcription
9.10E-07 8.48E-11 GO:0043921 6/21 Modulation by host of viral transcription
9.20E-07 8.58E-11 GO:0032774 16/557 RNA biosynthetic process
1.10E-06 1.03E-10 GO:2000112 34/3051 Regulation of cellular macromolecule biosynthetic process
1.20E-06 1.12E-10 GO:0052312 6/22 Modulation of transcription in other organism involved in symbiotic interaction
1.80E-06 1.68E-10 GO:0010556 34/3111 Regulation of macromolecule biosynthetic process
2.10E-06 1.96E-10 GO:0045893 19/896 Positive regulation of transcription, DNA-dependent
3.20E-06 2.98E-10 GO:0016071 16/606 mRNA metabolic process
3.50E-06 3.26E-10 GO:0048523 30/2478 Negative regulation of cellular process
5.40E-06 5.03E-10 GO:0051254 19/947 Positive regulation of RNA metabolic process
6.20E-06 5.78E-10 GO:0051851 6/28 Modification by host of symbiont morphology or physiology
6.70E-06 6.25E-10 GO:0010628 19/960 Positive regulation of gene expression
7.20E-06 6.71E-10 GO:0045935 20/1083 Positive regulation of nucleobase-containing compound metabolic process
8.60E-06 8.02E-10 GO:0031326 34/3291 Regulation of cellular biosynthetic process
9.50E-06 8.86E-10 GO:0019222 41/4731 Regulation of metabolic process
1.00E-05 9.32E-10 GO:0043922 5/14 Negative regulation by host of viral transcription
1.00E-05 9.32E-10 GO:0051173 20/1106 Positive regulation of nitrogen compound metabolic process
1.10E-05 1.03E-09 GO:0009889 34/3319 Regulation of biosynthetic process
1.20E-05 1.12E-09 GO:0016568 13/392 Chromatin modification
1.20E-05 1.12E-09 GO:0051702 6/31 Interaction with symbiont
1.70E-05 1.58E-09 GO:0006325 14/489 Chromatin organization
1.90E-05 1.77E-09 GO:0010557 19/1023 Positive regulation of macromolecule biosynthetic process
2.00E-05 1.86E-09 GO:0006366 12/330 Transcription from RNA polymerase II promoter
2.20E-05 2.05E-09 GO:0032897 5/16 Negative regulation of viral transcription
2.30E-05 2.14E-09 GO:0006357 19/1034 Regulation of transcription from RNA polymerase II promoter
3.20E-05 2.98E-09 GO:0048519 30/2715 Negative regulation of biological process
4.30E-05 4.01E-09 GO:0044419 13/436 Interspecies interaction between organisms
1.50E-04 1.40E-08 GO:0006369 6/46 Termination of RNA polymerase II transcription
1.50E-04 1.40E-08 GO:0031328 19/1160 Positive regulation of cellular biosynthetic process
1.70E-04 1.58E-08 GO:0044237 44/5889 Cellular metabolic process
1.90E-04 1.77E-08 GO:0051817 6/48 Modification of morphology or physiology of other organism involved in symbiotic interaction
1.90E-04 1.77E-08 GO:0035821 6/48 Modification of morphology or physiology of other organism
2.00E-04 1.86E-08 GO:0009891 19/1179 Positive regulation of biosynthetic process
3.10E-04 2.89E-08 GO:0000377 9/194 RNA splicing, via transesterification reactions with bulged adenosine as nucleophile
3.10E-04 2.89E-08 GO:0000398 9/194 Nuclear mRNA splicing, via spliceosome
3.10E-04 2.89E-08 GO:0044403 7/89 Symbiosis, encompassing mutualism through parasitism
3.80E-04 3.54E-08 GO:0000375 9/199 RNA splicing, via transesterification reactions
4.90E-04 4.57E-08 GO:0043484 6/56 Regulation of RNA splicing
5.10E-04 4.75E-08 GO:0051276 14/640 Chromosome organization
7.00E-04 6.53E-08 GO:0048024 5/30 Regulation of nuclear mRNA splicing, via spliceosome
7.30E-04 6.81E-08 GO:0034645 19/1281 Cellular macromolecule biosynthetic process
8.00E-04 7.46E-08 GO:0044238 44/6177 Primary metabolic process
8.70E-04 8.11E-08 GO:0016570 9/219 Histone modification
9.70E-04 9.04E-08 GO:0016569 9/222 Covalent chromatin modification
9.80E-04 9.14E-08 GO:0009059 19/1305 Macromolecule biosynthetic process
1.00E-03 9.32E-08 GO:0010604 20/1454 Positive regulation of macromolecule metabolic process
1.80E-03 1.68E-07 GO:0046782 6/69 Regulation of viral transcription
2.30E-03 2.14E-07 GO:0031124 6/72 mRNA 3'-end processing
2.60E-03 2.42E-07 GO:0031325 20/1536 Positive regulation of cellular metabolic process
2.80E-03 2.61E-07 GO:0050684 5/39 Regulation of mRNA processing
3.40E-03 3.17E-07 GO:0048524 6/77 Positive regulation of viral reproduction
5.30E-03 4.94E-07 GO:0006353 6/83 Transcription termination, DNA-dependent
5.60E-03 5.22E-07 GO:0009893 20/1613 Positive regulation of metabolic process
6.60E-03 6.15E-07 GO:0031123 6/86 RNA 3'-end processing
8.90E-03 8.30E-07 GO:2000242 5/49 Negative regulation of reproductive process
9.20E-03 8.58E-07 GO:0090343 3/6 Positive regulation of cell aging
Analyzed Ser 
position
Oligo name Oligonucleotides 5’-3’
SV40_WT_F CTAGCATGGGAGCTTCACCCAAGAAGAAGAGAAAGGTGGG
SV40_WT_R AATTCCCACCTTTCTCTTCTTCTTGGGTGAAGCTCCCATG
Swi6_WT_F CTAGCATGGGAGCTTCACCCCTGAAGAAGCTGAAGATCGACGG
Swi6_WT_R AATTCCGTCGATCTTCAGCTTCTTCAGGGGTGAAGCTCCCATG
Swi6_P-1E_F CTAGCATGGGAGCTGAACCCCTGAAGAAGCTGAAGATCGACGG
Swi6_P-1E_R AATTCCGTCGATCTTCAGCTTCTTCAGGGGTTCAGCTCCCATG
Swi6_P-2E_F CTAGCATGGGAGCTGAACCCGCCCTGAAGAAGCTGAAGATCGACGG
Swi6_P-2E_R AATTCCGTCGATCTTCAGCTTCTTCAGGGCGGGTTCAGCTCCCATG
Swi6_P0_F CTAGCATGGGAGCTGAACCCAAGAAGCTGAAGATCGACGG
Swi6_P0_R AATTCCGTCGATCTTCAGCTTCTTGGGTTCAGCTCCCATG
ATR_WT_F CTAGCATGGGAGCTATCAGCCCCAAGAGAAGAAGACTGGG
ATR_WT_R AATTCCCAGTCTTCTTCTCTTGGGGCTGATAGCTCCCATG
ATR_E_F CTAGCATGGGAGCTATCGAACCCAAGAGAAGAAGACTGGG
ATR_E_R AATTCCCAGTCTTCTTCTCTTGGGTTCGATAGCTCCCATG
CCLN2_WT_F CTAGCATGGGAGCTGCCAGCCCCAAGAGAAGAAAGAGCGG
CCLN2_WT_R AATTCCGCTCTTTCTTCTCTTGGGGCTGGCAGCTCCCATG
CCLN2_E_F CTAGCATGGGAGCTGCCGAACCCAAGAGAAGAAAGAGCGG
CCLN2_E_R AATTCCGCTCTTTCTTCTCTTGGGTTCGGCAGCTCCCATG
TFAP4_WT_F CTAGCATGGGAGCTAGCAGCCCCAAGAGAAGAAGAGCCGG
TFAP4_WT_R AATTCCGGCTCTTCTTCTCTTGGGGCTGCTAGCTCCCATG
TFAP4_EP0_F CTAGCATGGGAGCTAGCGAGCCCAAGAGAAGAAGAGCCGG
TFAP4_EP0_R AATTCCGGCTCTTCTTCTCTTGGGCTCGCTAGCTCCCATG
TFAP4_EP-1_F CTAGCATGGGAGCTGAGAGCCCCAAGAGAAGAAGAGCCGG
TFAP4_EP-1_R AATTCCGGCTCTTCTTCTCTTGGGGCTCTCAGCTCCCATG
CUL4B_WT_F CTAGCATGGGAGCTACCAGCGCCAAGAAGAGAAAGCTGGG
CUL4B_WT_R AATTCCCAGCTTTCTCTTCTTGGCGCTGGTAGCTCCCATG
CUL4B_EP0_F CTAGCATGGGAGCTACCGAGGCCAAGAAGAGAAAGCTGGG
CUL4B_EP0_R AATTCCCAGCTTTCTCTTCTTGGCCTCGGTAGCTCCCATG
CUL4B_EP-1_F CTAGCATGGGAGCTGAGAGCGCCAAGAAGAGAAAGCTGGG
CUL4B_EP-1_R AATTCCCAGCTTTCTCTTCTTGGCGCTCTCAGCTCCCATG
EP300_WT_F CTAGCATGGGAGCTCCCAGCGCCAAGAGACCCAAGCTGGG
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S53 (P0)    T52 
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EP300_WT_R AATTCCCAGCTTGGGTCTCTTGGCGCTGGGAGCTCCCATG
EP300_E_F CTAGCATGGGAGCTCCCGAAGCCAAGAGACCCAAGCTGGG
EP300_E_R AATTCCCAGCTTGGGTCTCTTGGCTTCGGGAGCTCCCATG
UIMC1_WT_F CTAGCATGGGAGCTGTGAGCGTGAAGAGAAAGAGAAGAGG
UIMC1_WT_R AATTCCTCTTCTCTTTCTCTTCACGCTCACAGCTCCCATG
UIMC1_E_F CTAGCATGGGAGCTGTGGAAGTGAAGAGAAAGAGAAGAGG
UIMC1_E_R AATTCCTCTTCTCTTTCTCTTCACTTCCACAGCTCCCATG
RREB1_WT_F CTAGCATGGGAGCTAGCCCCCTGAAGAGAAGAAGACTGGG
RREB1_WT_R AATTCCCAGTCTTCTTCTCTTCAGGGGGCTAGCTCCCATG
RREB1_E_F CTAGCATGGGAGCTGAACCCCTGAAGAGAAGAAGACTGGG
RREB1_E_R AATTCCCAGTCTTCTTCTCTTCAGGGGTTCAGCTCCCATG
TLX3_WT_F CTAGCATGGGAGCTACCCCCCCCAAGAGAAAGAAGCCCGG
TLX3_WT_R AATTCCGGGCTTCTTTCTCTTGGGGGGGGTAGCTCCCATG
TLX3_E_F CTAGCATGGGAGCTGAGCCCCCCAAGAGAAAGAAGCCCGG
TLX3_E_R AATTCCGGGCTTCTTTCTCTTGGGGGGCTCAGCTCCCATG
SRRM2_WT_F CTAGCATGGGAGCTACCCCCGCCAAGAGAAAGAGAAGAGG
SRRM2_WT_R AATTCCTCTTCTCTTTCTCTTGGCGGGGGTAGCTCCCATG
SRRM2_E_F CTAGCATGGGAGCTGAGCCCGCCAAGAGAAAGAGAAGAGG
SRRM2_E_R AATTCCTCTTCTCTTTCTCTTGGCGGGCTCAGCTCCCATG
UBA E1_WT_F CTAGCATGGGAGCTTCGCCGCTGTCCAAGAAACGTCGCGTGGG
UBA E1_WT_R AATTCCCACGCGACGTTTCTTGGACAGCGGCGAAGCTCCCATG
UBA E1_EP-2_F CTAGCATGGGAGCTGAACCGCTGTCCAAGAAACGTCGCGTGGG
UBA E1_EP-2_R AATTCCCACGCGACGTTTCTTGGACAGCGGTTCAGCTCCCATG
UBA E1_EP-1_F CTAGCATGGGAGCTGAACCGTCCAAGAAACGTCGCGTGGG
UBA E1_EP-1_R AATTCCCACGCGACGTTTCTTGGACGGTTCAGCTCCCATG
UNG_WT_F CTAGCATGGGAGCTTCACCCGCCAGGAAGCGACACGCCCCCGG
UNG_WT_R AATTCCGGGGGCGTGTCGCTTCCTGGCGGGTGAAGCTCCCATG
UNG_EP-2_F CTAGCATGGGAGCTGAACCCGCCAGGAAGCGACACGCCCCCGG
UNG_EP-2_R AATTCCGGGGGCGTGTCGCTTCCTGGCGGGTTCAGCTCCCATG
UNG_EP-1_F CTAGCATGGGAGCTGAACCCAGGAAGCGACACGCCCCCGG
UNG_EP-1_R AATTCCGGGGGCGTGTCGCTTCCTGGGTTCAGCTCCCATG
K18N_F CTAGCATGGGAGCTAGCCCCGCCAGGAACCGACACGCCCCCGG
K18N_R AATTCCGGGGGCGTGTCGGTTCCTGGCGGGGCTAGCTCCCATG
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p53_WT_F CTAGCATGGGAGCTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGG
p53_WT_E AATTCCCAGTGGTTTCTTCTTTGGCTGGGGAGAGGAGCTGGTGTTGTTGGGCAGTGCTCGCTTAGCTCCCATG
p53_EP-2_F CTAGCATGGGAGCTAAGCGAGCACTGCCCAACAACACCAGCTCCGAACCCCAGCCAAAGAAGAAACCACTGGG
p53_EP-2_R AATTCCCAGTGGTTTCTTCTTTGGCTGGGGTTCGGAGCTGGTGTTGTTGGGCAGTGCTCGCTTAGCTCCCATG
P53_EP-1_F CTAGCATGGGAGCTAAGCGAGCACTGCCCAACAACACCAGCTCCGAACCCCCAAAGAAGAAACCACTGGG
P53_EP-1_R AATTCCCAGTGGTTTCTTCTTTGGGGGTTCGGAGCTGGTGTTGTTGGGCAGTGCTCGCTTAGCTCCCATG
DUT_WT_F TTAAGGGCCTTGCCTCACCCAGTAAGCGGGCCCGGCCTGCGT
DUT_WT_R CTAGACGCAGGCCGGGCCCGCTTACTGGGTGAGGCAAGGCCC
DUT_E_F TTAAGGGCCTTGCCGAACCCAGTAAGCGGGCCCGGCCTGCGT
DUT_E_F CTAGACGCAGGCCGGGCCCGCTTACTGGGTTCGGCAAGGCCC
LMNA_WT_F TTAAGGGCCTTGCCAGCGTGACCAAGAAGAGAAAGCTGT
LMNA_WT_R CTAGACAGCTTTCTCTTCTTGGTCACGCTGGCAAGGCCC
LMNA_E_F TTAAGGGCCTTGCCGAAGTGACCAAGAAGAGAAAGCTGT
LMNA_E_R CTAGACAGCTTTCTCTTCTTGGTCACTTCGGCAAGGCCC
BAZ2A_WT_F TTAAGGGCCTTGCCAGCCCCAGCAAGAGAAGAAGACTGT
BAZ2A_WT_R CTAGACAGTCTTCTTCTCTTGCTGGGGCTGGCAAGGCCC
BAZ2A_E_F TTAAGGGCCTTGCCGAACCCAGCAAGAGAAGAAGACTGT
BAZ2A_WT_R CTAGACAGTCTTCTTCTCTTGCTGGGTTCGGCAAGGCCC 
galN1F GCAAGAATTCCAGCATCGTTTACTTTGACCAACAAGAACG
galN1R AATTGGTACCGCTTTTTGACACCAGACCAACTGGTAATGG
dutpETF GGAATTCCATATGCCCTGCTCTGAAGAGACAC
dutpETR CCGCTCGAGCTGGGAGCCGGAGTGG
p53_F AGCTCTCGAGATGGAGGAGCCGCAGTCAGATC
p53_R CACTGGATCCTCAGTCTGAGTCAGGCCCTTCTG
UBA1_F CAGCTGGTACCATGTCCAGCTCGCCGCTGTCC
UBA1_R AGATGGATCCGCTCCGCGGATGGTGTATCGGACATAGG
UNG2_F CGATCTCGAGATGATCGGCCAGAAGACGC
UNG2_R ACGGTACCGCGATGTACCTGTAGGTGTCCAGC
S11E_F GAGACACCCGCCATTGAACCCAGTAAGCGGGC
S11E_R GCCCGCTTACTGGGTTCAATGGCGGGTGTCTC
S11Q_F GAGACACCCGCCATTCAACCCAGTAAGCGGGC
S11Q_R GCCCGCTTACTGGGTTGAATGGCGGGTGTCTC
S315E_F (P-2) CCCAACAACACCAGCTCCGAACCCCAGCCAAAGAAGAAACC
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Cloning p53 into    pDsRed-
Monomer-C1
Cloning dUTPase into pET20b 
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Cloning UBA1 into pDsRed-
Monomer-N1
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Cloning β-gal into  pDsRed-
Monomer-N1  
S414
S1783
dUTPase (in 
pET20b)
Cloning UNG2 into pDsRed-
Monomer-N1
S315E_R (P-2) GGTTTCTTCTTTGGCTGGGGTTCGGAGCTGGTGTTGTTGGG
Q317Δ_F (P-1) ACACCAGCTCCGAACCCCCAAAGAAGAAACCACTGGATG
Q317Δ_F (P-1) CATCCAGTGGTTTCTTCTTTGGGGGTTCGGAGCTGGTGT
S4E_F (P-2) CGACGGTACCATGTCCAGCGAACCGCTGTCCAAGAAACGTC
S4E_R (P-2) GACGTTTCTTGGACAGCGGTTCGCTGGACATGGTACCGTCG
L6Δ_F (P-1) GTACCATGTCCAGCGAACCGTCCAAGAAACGTCGCGTGTC
L6Δ_R (P-1) GACACGCGACGTTTCTTGGACGGTTCGCTGGACATGGTAC
S14E_F (P-2) CTACTCCTTTTTCTCCCCCGAACCCGCCAGGAAGCGAC
S14E_R (P-2) GTCGCTTCCTGGCGGGTTCGGGGGAGAAAAAGGAGTAG
A16Δ_F (P-1) CCTTTTTCTCCCCCGAACCCAGGAAGCGACACGCCCC
A16Δ_R (P-1) GGGGCGTGTCGCTTCCTGGGTTCGGGGGAGAAAAAGG
p53
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